Treatment News : Viread During Pregnancy Lowers Babies’ Bone Density

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » March 2014

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 21, 2014

Viread During Pregnancy Lowers Babies’ Bone Density

CROI 2014Women who take Viread (tenofovir) during pregnancy give birth to babies with lowered bone density, although the longterm implication of this finding is unclear, MedPage Today reports. Researchers conducted a study of HIV-positive pregnant participants in the Pediatric HIV/AIDS Cohort Study and presented their findings at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.

The investigators evaluated a total of 143 dual-energy x-ray absorptiometray (DXA) scans.  The tests were taken to determine the whole-body bone mineral content of infants born to these mothers, including 74 whose mothers’ took Viread and 69 whose mothers who took other HIV drugs. Babies born to the mothers who took Viread had an average whole-body bone mineral content of 56 grams, compared with 63.8 grams for infants born to the other mothers. This represented a 12.2 percent difference.

The investigators plan to study if these differences in bone mineral density persist and result in a clinical impact. At this time the scientists cannot make any recommendations about altering treatment guidelines for pregnant mothers.

To read the MedPage Today story, click here.

Search: Bone density, infants, Viread, tenofovir, pregnancy, Pediatric HIV/AIDS Cohort Study, Conference on Retroviruses and Opportunistic Infections, CROI.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    Drew949
    South Orange County
    California


    Loveladyd
    Washington
    DC


    TaintedloveDC
    Washington
    DC


    humboman
    Baltimore
    Maryland
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you work with your doc to design your own treatment regimen?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.